Table 1 Baseline characteristics by ability to complete self-imaging
From: Evaluation of a self-imaging SD-OCT system designed for remote home monitoring
Completed self-imaging NVHO 2.5 | Could not complete self-imaging NVHO 2.5 | Total / p-value | Completed self-imaging NVHO 3 | Could not complete self-imaging NVHO 3 | Total / p-value | |
|---|---|---|---|---|---|---|
N (%) - patients | 264 (91) | 26 (9) | 290 | 45 | 0 | |
N (%) - eyes | 469 (88) | 62 (12) | 531 | 69 | 5 | 74 |
Age (SD) | 78.8 (8.8) | 84.3 (7.8) | < 0.001 | 79.5 (6.5) | 84.0 (1.4) | 0.14 |
Gender, n (%) female | 153 (58) | 15 (56) | 23 (51) | 2, (40) | ||
LogMAR VA, Mean (SD) | 0.35 (0.30) | 0.58 (0.41) | < 0.001 | 0.29 (0.30) | 0.47 (0.25) | 0.2 |
Mean VA Snellen equivalent | 20/45 | 20/76 | 20/39 | 20/59 | ||
LogMAR VA, Median (IQR) | 0.30 (0.2,0.48) | 0.52 (0.22,0.88) | 0.18 (0.10,0.40) | 0.52 (0.40–0.7) | ||
Median VA Snellen equivalent | 20/40 | 20/66 | 20/30 | 20/66 | ||
Visual acuity, n (%) | ||||||
≥20/40 | 293 (62) | 26 (42) | 48 (69.6) | 1 (20) | ||
< 20/40–20/80 | 99 (21) | 11 (18) | 14 (20.9) | 2 (40) | ||
< 20/80–20/160 | 40 (9) | 10 (16) | 0 (0) | 2 (40) | ||
< 20/160–20/320 | 28 (6) | 6 (10) | 7 (10.1) | – | ||
< 20/320–20/400 | 9 (2) | 9 (15) | 0 (0) | – | ||
Diagnosis, n (%)a | ||||||
Early AMD | 38 (8.1) | 6 (8.7) | ||||
Intermediate AMD | 121 (25.8) | – | 16 (23.2) | |||
Neovascular AMD | 310 (66.1) | 47 (68.1) | ||||